X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (229) 229
Book Review (30) 30
Publication (17) 17
Book Chapter (6) 6
Book / eBook (3) 3
Conference Proceeding (3) 3
Patent (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (132) 132
humans (125) 125
endocrinology & metabolism (91) 91
male (82) 82
female (80) 80
middle aged (77) 77
adult (72) 72
aged (68) 68
tumors (39) 39
abridged index medicus (34) 34
oncology (27) 27
somatostatin - analogs & derivatives (25) 25
young adult (24) 24
diagnosis (19) 19
management (19) 19
adolescent (18) 18
medicine & public health (18) 18
neuroendocrine tumors (18) 18
somatostatin (18) 18
surgery (18) 18
treatment outcome (18) 18
aged, 80 and over (17) 17
expression (17) 17
cancer (16) 16
octreotide - therapeutic use (16) 16
disease (15) 15
prognosis (15) 15
research (15) 15
retrospective studies (15) 15
somatostatin - therapeutic use (15) 15
therapy (15) 15
patients (14) 14
corticosteroids (13) 13
secretion (13) 13
cushing syndrome (12) 12
hormones (12) 12
in-vitro (12) 12
mortality (12) 12
prospective studies (12) 12
survival (12) 12
analysis (11) 11
animals (11) 11
follow-up studies (11) 11
octreotide - analogs & derivatives (11) 11
receptors, somatostatin - metabolism (11) 11
tumor cells, cultured (11) 11
acromegaly - drug therapy (10) 10
cortisol (10) 10
dopamine (10) 10
growth-hormone (10) 10
neuroendocrine tumors - pathology (10) 10
octreotide (10) 10
pituitary (10) 10
pituitary neoplasms - drug therapy (10) 10
quality-of-life (10) 10
somatostatin - pharmacology (10) 10
acth (9) 9
adrenocorticotropic hormone (9) 9
care and treatment (9) 9
child (9) 9
cushing's syndrome (9) 9
glucocorticoids (9) 9
health aspects (9) 9
hydrocortisone (9) 9
internal medicine (9) 9
metastases (9) 9
paraganglioma (9) 9
pharmacology & pharmacy (9) 9
risk factors (9) 9
rna, messenger - metabolism (9) 9
adrenal glands (8) 8
biomarkers (8) 8
cell line, tumor (8) 8
dopamine agonists - therapeutic use (8) 8
dose-response relationship, drug (8) 8
hypertension (8) 8
metastasis (8) 8
octreotide - adverse effects (8) 8
octreotide - pharmacology (8) 8
pancreas (8) 8
physiological aspects (8) 8
prevalence (8) 8
receptor (8) 8
receptors, somatostatin - genetics (8) 8
transsphenoidal surgery (8) 8
adrenal cortex neoplasms - pathology (7) 7
adrenocortical carcinoma - pathology (7) 7
carcinoma (7) 7
case-control studies (7) 7
cells (7) 7
cushings-syndrome (7) 7
diabetes (7) 7
endocrine system (7) 7
endocrine tumors (7) 7
endocrinology (7) 7
enets consensus guidelines (7) 7
gene-expression (7) 7
hydrocortisone - blood (7) 7
hydrocortisone - metabolism (7) 7
hypercortisolism (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 13, pp. 2124 - 2130
Purpose Despite the fact that most gastroenteropancreatic neuroendocrine tumors (GEPNETs) are slow-growing, median overall survival ( OS) in patients with... 
LIVER METASTASES | STREPTOZOCIN | CHEMOEMBOLIZATION | SOUTHWEST-ONCOLOGY-GROUP | ONCOLOGY | CARCINOID-TUMORS | RADIONUCLIDE THERAPY | ENDOCRINE TUMORS | PHASE-II | METASTATIC NEUROENDOCRINE TUMORS | EPIDEMIOLOGY | Gastrointestinal Neoplasms - mortality | Humans | Middle Aged | Male | Gastrointestinal Neoplasms - pathology | Time Factors | Myelodysplastic Syndromes - chemically induced | Neuroendocrine Tumors - diagnostic imaging | Aged, 80 and over | Organometallic Compounds - therapeutic use | Adult | Female | Pancreatic Neoplasms - mortality | Neuroendocrine Tumors - pathology | Severity of Illness Index | Hematologic Diseases - chemically induced | Octreotide - analogs & derivatives | Risk Assessment | Organometallic Compounds - adverse effects | Pancreatic Neoplasms - pathology | Proportional Hazards Models | Carcinoid Tumor - diagnostic imaging | Octreotide - adverse effects | Logistic Models | Treatment Outcome | Octreotide - therapeutic use | Carcinoid Tumor - pathology | Disease-Free Survival | Gastrointestinal Neoplasms - diagnostic imaging | Neuroendocrine Tumors - mortality | Radionuclide Imaging | Aged | Chemical and Drug Induced Liver Injury | Radiopharmaceuticals - adverse effects | Carcinoid Tumor - mortality | Pancreatic Neoplasms - diagnostic imaging | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
Journal Article
Journal Article
Journal of nuclear medicine, ISSN 0161-5505, 2015, Volume 56, Issue 11, pp. 1647 - 1653
Journal Article
ENDOCRINE-RELATED CANCER, ISSN 1351-0088, 06/2019, Volume 26, Issue 6, pp. 585 - 599
Control of symptoms related to hormonal hypersecretion by functioning neuroendocrine tumors (NETs) is challenging. New therapeutic options are required. Since... 
OCTREOTIDE | hormone secretion | somatostatin-dopamine chimeric drugs | NEOPLASMS | ENETS CONSENSUS GUIDELINES | LUNG CARCINOIDS | SPHEROIDS | ONCOLOGY | RECEPTOR LIGANDS | CABERGOLINE | ENDOCRINOLOGY & METABOLISM | GENE-EXPRESSION | PITUITARY | SECRETION | 3D cell cultures | neuroendocrine tumors
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 06/2017, Volume 102, Issue 6, pp. 2009 - 2018
Journal Article
Journal Article
Journal Article
Journal Article
Clinical Endocrinology, ISSN 0300-0664, 01/2019, Volume 90, Issue 1, pp. 232 - 240
Context Corticosteroid-binding globulin (CBG) and albumin transport circulating cortisol. Cleavage of high-affinity CBG (haCBG) by neutrophil elastase at... 
mortality | cortisol | CBG | septic shock | corticosteroid‐binding globulin | corticosteroid-binding globulin | PROTEIN | FLUDROCORTISONE | INTACT | HYDROCORTISONE | PLASMA | THERAPY | REACTIVE CENTER LOOP | ENDOCRINOLOGY & METABOLISM | SEVERE SEPSIS | Shock | Adrenal glands | Glucocorticoids | Immunomodulation | Mortality | Albumin | Septic shock | Inflammation | Hormones | Hydrocortisone | Patients | Globulins | Sepsis | Affinity | Elastase
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 08/2017, Volume 58, Issue 8, pp. 1236 - 1242
Pheochromocytoma/paraganglioma (PPGL) syndromes associated with polycythemia have previously been described in association with mutations in the von... 
F-FDA; pheochromocytoma; paraganglioma; polycythemia | F-FDOPA | polycythemia | LOCALIZATION | METASTATIC PHEOCHROMOCYTOMA | pheochromocytoma | MODALITIES | ERYTHROCYTOSIS | paraganglioma | SUPERIORITY | POSITRON-EMISSION-TOMOGRAPHY | F-18-FDOPA |